Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)
- Status
- RECRUITING
- Phase
- PHASE2
SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients
- Status
- RECRUITING
- Phase
- PHASE2
Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Botensilimab and Balstilimab Optimization in Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
First In Human Study of CX-2051 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1